Pulse Biosciences, Inc. (PLSE) [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Revenues:
System Products	0.6	1.2
Cycle Units Products	0.1	0.2
Rest of World	0.2	0.2
North America	0.5	1.2
Total revenues	0.7	1.4	0.0	0.0	0.0	1.0	0.6	0.4
Revenue growth [+]	-50.6%				-100.0%	84.3%	42.0%
System Products	-52.9%
Cycle Units Products	-38.9%
Rest of World	-22.5%
North America	-56.3%
Cost of goods sold	11.9	2.0	0.0	0.6	0.6	0.8	0.5	0.4
Gross profit	-11.2	-0.6	0.0	-0.6	-0.6	0.2	0.1	0.0
Gross margin	-1606.3%	-38.8%				23.6%	12.0%	0.0%
Selling, general and administrative [+]	26.0	33.8	23.5	47.4	38.0	15.5	3.4	1.6
Sales and marketing	12.0	14.8	7.3
General and administrative	14.0	19.1	16.3			15.5	3.4	1.6
Research and development	20.8	28.6	26.4			9.6	5.5	2.2
Other operating expenses				-2.0	-38.6		0.7	0.7
EBITDA [+]	-56.7	-61.9	-48.9			-24.6	-8.8	-3.8
EBITDA growth	-8.4%	26.6%	6.3%		-100.0%	180.5%	133.5%
EBITDA margin	-8100.3%	-4363.0%				-2346.3%	-1542.1%	-937.8%
Depreciation	0.7	0.5	0.4	-0.7	-0.7	0.3	0.1	0.1
EBITA	-57.4	-62.3	-49.3	-45.3	0.7	-24.9	-8.9	-3.8
EBITA margin	-8198.9%	-4396.9%				-2378.4%	-1558.6%	-950.5%
Amortization of intangibles	0.7	0.7	0.7	0.7	0.7	0.7	0.7	0.7
EBIT [+]	-58.1	-63.0	-50.0	-46.0	0.0	-25.6	-9.5	-4.5
EBIT growth	-7.9%	26.1%	8.6%		-100.0%	168.6%	113.0%
EBIT margin	-8293.9%	-4443.9%				-2441.9%	-1675.7%	-1117.0%
Interest expense, net [+]	0.4	0.6	-0.1			-0.2	-0.1
Interest expense	0.4	0.6
Interest income			0.1			0.2	0.1
Other income (expense), net				-1.0	-37.5	-0.2	-0.1
Pre-tax income	-58.5	-63.7	-49.9	-47.0	-37.5	-25.6	-9.5	-4.5
Income taxes	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-1.7
Tax rate	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	37.1%
Net income	-58.5	-63.7	-49.9	-47.0	-37.5	-25.6	-9.5	-2.8
Net margin	-8357.9%	-4489.4%				-2441.9%	-1675.7%	-702.8%

Basic EPS [+]	($1.72)	($2.28)	($2.14)	($2.26)	($2.20)	($1.73)	($0.86)	($0.37)
Growth	-24.3%	6.2%	-5.3%	3.0%	26.9%	100.4%	132.7%
Diluted EPS [+]	($1.72)	($2.28)	($2.14)	($2.26)	($2.20)	($1.73)	($0.86)	($0.37)
Growth	-24.3%	6.2%	-5.3%	3.0%	26.9%	100.4%	132.7%

Shares outstanding (basic) [+]	33.9	28.0	23.2	20.7	17.1	14.8	11.0	7.6
Growth	21.4%	20.3%	12.1%	21.5%	15.8%	34.0%	45.5%
Shares outstanding (diluted) [+]	33.9	28.0	23.2	20.7	17.1	14.8	11.0	7.6
Growth	21.4%	20.3%	12.1%	21.5%	15.8%	34.0%	45.5%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.